Directors’ Dealings | 29 September 2014 14:15

DGAP-DD: STADA Arzneimittel AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a service of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Retzlaff First name: Hartmut Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: Warrant ISIN/WKN of the financial instrument: DE0007251845 Type of transaction: Sale Date: 29.09.2014 Price: 311.1325 Currency: EUR No. of items: 2000 Total amount traded: 622265 Place: Xetra Description of the derivative Description of the underlying instrument: Share Underlying (WKN/ISIN): DE0007251803 Price multiplier: 20 Strike price: 16.45 Currency: EUR Expiration date: 26.06.2015 Information about the company with duty of publication Issuer: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Deutschland ISIN: DE0007251803 WKN: 725180 End of Directors’ Dealings Notification (c) DGAP 29.09.2014 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 19547